FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386009767> ?p ?o ?g. }

• W4386009767 endingPage "107351" @default.
• W4386009767 startingPage "107351" @default.
• W4386009767 abstract "Immune checkpoint inhibitor-related interstitial lung disease (ICI-ILD) is a serious adverse event frequently observed in patients with non-small cell lung cancer (NSCLC). We investigated the clinical effects and mechanism of action of ICI-ILD in NSCLC patients treated with ICI.We retrospectively screened patients with advanced or recurrent NSCLC who received PD-1/PD-L1 inhibitor monotherapy and examined the prognostic impact of ICI-ILD. In addition, we analyzed the levels of 72 different soluble immune mediators in pre-treatment plasma to explore possible mechanisms associated with the development of ICI-ILD. Furthermore, the relationships between soluble immune mediators associated with ICI-ILD development and survival were analyzed.Of 141 patients with NSCLC, 25 (17.7%) developed ICI-ILD. Logistic regression analysis revealed that pre-treatment CXCL9, MMP-1, IL-6, and IL-19 levels were associated with ICI-ILD development. There were no significant differences in progression-free survival (PFS) and overall survival (OS) between patients with or without ICI-ILD. In patients with ICI-ILD, patients with lower grade ICI-ILD had better OS than those with higher-grade ICI-ILD. In ICI-ILD patients, there was a trend for patients with lower-grade ICI-ILD to have better PFS and OS than those with higher-grade ICI-ILD. Among four soluble immune mediators associated with ICI-ILD, a high level of IL-19 was significantly correlated with worse OS and PFS.The identified soluble immune mediators, including CXCL9, MMP-1, IL-6, and IL-19, may be useful as biomarkers to associate with ICI-ILD development. Although we did not detect significant differences in PFS and OS between patients with and without ICI-ILD, PFS and OS were longer in those with lower-grade ICI-ILD than in patients with higher-grade ICI-ILD. Among biomarkers, IL-19 may be a causal and prognostic factor for ICI-ILD." @default.
• W4386009767 created "2023-08-21" @default.
• W4386009767 creator A5000734437 @default.
• W4386009767 creator A5020304167 @default.
• W4386009767 creator A5045245886 @default.
• W4386009767 creator A5045491062 @default.
• W4386009767 creator A5063394469 @default.
• W4386009767 creator A5065999131 @default.
• W4386009767 creator A5083502759 @default.
• W4386009767 creator A5083594914 @default.
• W4386009767 date "2023-10-01" @default.
• W4386009767 modified "2023-10-18" @default.
• W4386009767 title "Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer" @default.
• W4386009767 cites W1676246072 @default.
• W4386009767 cites W2080571923 @default.
• W4386009767 cites W2083576842 @default.
• W4386009767 cites W2088258412 @default.
• W4386009767 cites W2093979559 @default.
• W4386009767 cites W2105632276 @default.
• W4386009767 cites W2107467158 @default.
• W4386009767 cites W2125616358 @default.
• W4386009767 cites W2152897456 @default.
• W4386009767 cites W2275321938 @default.
• W4386009767 cites W2289712604 @default.
• W4386009767 cites W2301027955 @default.
• W4386009767 cites W2508205285 @default.
• W4386009767 cites W2508623887 @default.
• W4386009767 cites W2527905628 @default.
• W4386009767 cites W2529484692 @default.
• W4386009767 cites W2581283430 @default.
• W4386009767 cites W2759963646 @default.
• W4386009767 cites W2791728959 @default.
• W4386009767 cites W2887632081 @default.
• W4386009767 cites W2889197569 @default.
• W4386009767 cites W2891486030 @default.
• W4386009767 cites W2896117726 @default.
• W4386009767 cites W2945590213 @default.
• W4386009767 cites W3015929829 @default.
• W4386009767 cites W3039168731 @default.
• W4386009767 cites W3048608605 @default.
• W4386009767 cites W3094997487 @default.
• W4386009767 cites W3095039939 @default.
• W4386009767 cites W3095154565 @default.
• W4386009767 cites W3105728018 @default.
• W4386009767 cites W3109793392 @default.
• W4386009767 cites W3116084499 @default.
• W4386009767 cites W3123570655 @default.
• W4386009767 cites W3126292443 @default.
• W4386009767 cites W3132509156 @default.
• W4386009767 cites W3165585845 @default.
• W4386009767 cites W3170001459 @default.
• W4386009767 cites W3204330487 @default.
• W4386009767 cites W4283264207 @default.
• W4386009767 cites W4292183344 @default.
• W4386009767 cites W4310010234 @default.
• W4386009767 cites W4316115019 @default.
• W4386009767 cites W4376643165 @default.
• W4386009767 cites W865168492 @default.
• W4386009767 doi "https://doi.org/10.1016/j.lungcan.2023.107351" @default.
• W4386009767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37639819" @default.
• W4386009767 hasPublicationYear "2023" @default.
• W4386009767 type Work @default.
• W4386009767 citedByCount "0" @default.
• W4386009767 crossrefType "journal-article" @default.
• W4386009767 hasAuthorship W4386009767A5000734437 @default.
• W4386009767 hasAuthorship W4386009767A5020304167 @default.
• W4386009767 hasAuthorship W4386009767A5045245886 @default.
• W4386009767 hasAuthorship W4386009767A5045491062 @default.
• W4386009767 hasAuthorship W4386009767A5063394469 @default.
• W4386009767 hasAuthorship W4386009767A5065999131 @default.
• W4386009767 hasAuthorship W4386009767A5083502759 @default.
• W4386009767 hasAuthorship W4386009767A5083594914 @default.
• W4386009767 hasConcept C126322002 @default.
• W4386009767 hasConcept C143998085 @default.
• W4386009767 hasConcept C197934379 @default.
• W4386009767 hasConcept C203014093 @default.
• W4386009767 hasConcept C2776256026 @default.
• W4386009767 hasConcept C2777543607 @default.
• W4386009767 hasConcept C2777714996 @default.
• W4386009767 hasConcept C71924100 @default.
• W4386009767 hasConcept C8891405 @default.
• W4386009767 hasConcept C90924648 @default.
• W4386009767 hasConceptScore W4386009767C126322002 @default.
• W4386009767 hasConceptScore W4386009767C143998085 @default.
• W4386009767 hasConceptScore W4386009767C197934379 @default.
• W4386009767 hasConceptScore W4386009767C203014093 @default.
• W4386009767 hasConceptScore W4386009767C2776256026 @default.
• W4386009767 hasConceptScore W4386009767C2777543607 @default.
• W4386009767 hasConceptScore W4386009767C2777714996 @default.
• W4386009767 hasConceptScore W4386009767C71924100 @default.
• W4386009767 hasConceptScore W4386009767C8891405 @default.
• W4386009767 hasConceptScore W4386009767C90924648 @default.
• W4386009767 hasFunder F4320311405 @default.
• W4386009767 hasLocation W43860097671 @default.
• W4386009767 hasLocation W43860097672 @default.
• W4386009767 hasOpenAccess W4386009767 @default.
• W4386009767 hasPrimaryLocation W43860097671 @default.
• W4386009767 hasRelatedWork W1972945471 @default.

• next